FIELD: peptide and protein chemistry. SUBSTANCE: invention relates to nanometer-size structures used for constructing microscopic and macroscopic structures. Isolated polypeptide represents version gp 36 of bacteriophage T4 protein (amino acid sequence is given in description). Isolated fused protein consists of first part of gp 37 protein of T-even-similar bacteriophage and last 10-60 C-terminal amino acids of gp 36 protein or first segment of gp 36 protein and second segment of gp 34 protein of T-even-similar bacteriophage (amino acid sequences are given in description). EFFECT: enabled creation of materials with properties adapted for specific requirements nanometer-scale technology and increased strength and consistence of macrostructures. 6 cl, 29 dwg, 7 ex
Title |
Year |
Author |
Number |
E. COLI STRAIN - PRODUCER OF ISOLATED DOMAIN 1 OF PROTECTIVE BACILLUS ANTHRACIS ANTIGEN IN FORM OF VIRUS-LIKE PARTICLES |
2016 |
- Shibaeva Anna Valerevna
- Letarov Andrej Viktorovich
- Kulikov Evgenij Evgenevich
- Golomidova Alla Konstantinovna
- Pozdnyakova Natalya Vladimirovna
- Kuznetsova Tatyana Vladimirovna
- Smirnova Mariya Sergeevna
- Lebedeva Anna Aleksandrovna
- Biryukova Yuliya Konstantinovna
|
RU2633508C1 |
ECOLI STRAIN - PRODUCER OF FULL-DIMENSIONAL PROTECTIVE BACILLUS ANTHRACIS ANTIGEN IN FORM OF VIRUS-LIKE PARTICLES |
2016 |
- Ivanov Pavel Aleksandrovich
- Letarov Andrej Viktorovich
- Kulikov Evgenij Evgenevich
- Golomidova Alla Konstantinovna
- Trifan Valerij Nikandrovich
- Pozdnyakova Natalya Vladimirovna
- Shibaeva Anna Valerevna
- Biryukova Yuliya Konstantinovna
- Kuznetsova Tatyana Vladimirovna
|
RU2633504C1 |
ISOLATED KillerRed PROTEIN-CODING NUCLEIC ACID (VERSIONS), ISOLATED PROTEIN (VERSIONS), EXPRESSION CASSETTE, CELL CONTAINING EXPRESSION CASSETTE |
2011 |
- Luk'Janov Konstantin Anatol'Evich
- Serebrovskaja Ekaterina Olegovna
- Luk'Janov Sergej Anatol'Evich
|
RU2458129C1 |
CONSTRUCTION OF MODIFIED FILAMENTOUS BACTERIOPHAGE FOR TREATMENT OR PROPHYLAXIS OF BACTERIAL INFECTION, MODIFIED BACTERIOPHAGE M14, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF BACTERIAL INFECTION, MONOCLONAL ANTIBODY, HYBRIDOMA (VARIANT) |
1997 |
|
RU2215032C2 |
CONDITIONALLY ACTIVE BIOLOGICAL PROTEINS |
2016 |
- Short Dzhej M.
- Chan Khvaj Ven
- Frej Gerkhard
|
RU2733658C2 |
AFFINITY-MATURED CRIG VERSIONS |
2009 |
- Sidkhu, Sachdev, S.
- Li, Bin
- Van Lokeren Kampagne, Menno
- Vismann, Kristian
|
RU2553517C2 |
ISOLATED GLYCOPROTEIN IB ALPHA POLYPEPTIDE OF HUMAN THROMBOCYTES, FUSED PROTEIN, DNA MOLECULE (VERSIONS), EXPRESSION VECTOR (VERSIONS), CELL (VERSIONS), POLYPEPTIDE EXPRESSION METHOD, FUSED PROTEIN EXPRESSION METHOD, PHARMACEUTICAL COMPOSITION (VERSIONS), METHOD OF INHIBITING BODING OF BLOOD CELLS TO BIOLOGICAL TISSUE IN BIOLOGICAL SYSTEM, METHOD OF INHIBITING BONDING OF PROTEIN TO BIOLOGICAL TISSUE IN BIOLOGICAL SYSTEM AND DISORDER TREATMENT METHOD |
2004 |
- Sho Grej
- Sako Dajann S.
- Kumar Ravindra
- Sjuj Tszin'
|
RU2403262C2 |
RECEPTORS-MEDIATED DELIVERY OF GENES BY USING VECTORS BASED UPON BACTERIOPHAGES |
1998 |
- Larokka Dehvid
- Behjrd Ehndrju
- Dzhonson Uehndi
|
RU2209088C2 |
RECOMBINANT PLASMIDE DNA PPR-TGATG-HIL-Iβ-TSR WHICH PROVIDES SYNTHESIS OF RECOMBINANT INTERLEIKIN-1 AND STRAIN BSCHERICHIA COLI BEING PRODUCER OF RECOMBINANT HUMAN INTERLEIKIN-1 b |
1992 |
- Mashko S.V.
- Lebedeva M.I.
- Vinetskij Ju.P.
- Kotenko S.V.
- Ketlinskij S.A.
- Simbirtsev A.S.
- Kozlov A.P.
- Izotova L.S.
- Kozlov Ju.I.
- Debabov V.G.
|
RU2045575C1 |
DNA SEQUENCE, PROTEIN, METHOD OF PROTEIN PRODUCING |
1991 |
- Kendzi Mitsusima[Jp]
- Akio Takimoto[Jp]
- Sigeo Jagi[Jp]
- Takajasu Sonojama[Jp]
|
RU2103364C1 |